Top Markets
Coin of the day
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Clasificación en acciones #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Precio por acción
$45.79
Capitalización bursátil
$2.33B
Cambio (1 día)
11.43%
Cambio (1 año)
408.10%
País
FR
Comercio Nanobiotix S.A. (NANO)

Categoría

Historial del precio de la acción de Nanobiotix S.A. (NANO)
Precio más alto de cierre: $41.65 el 2026-08-01

Precio más bajo de cierre: $8.60 el 2012-10-01
Historial del precio de la acción de Nanobiotix S.A. desde 2012 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 29.51%
2025 582.51%
2024 -45.85%
2023 51.22%
2022 -50.99%
2021 -50.84%
2020 93.52%
2019 -37.58%
2018 -11.94%
2017 -7.30%
2016 -2.69%
2015 -15.40%
2014 172.96%
2013 -14.45%
2012 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$549.16 41.14%
US
$1.06K 49.18%
NL
$122.63 -12.65%
AU
$142.75 468.71%
US
$765.25 7.19%
CH